Christopher qualified in medicine from Cambridge University in 1988. Training in oncology was undertaken at Cambridge, Nottingham, Ipswich and the Royal Free, London. He has been an NHS Consultant in Ipswich since 1998. His chief clinical and research interests and expertise are in urological and head and neck and thyroid malignancies, the use and development of state-of-the-art radiotherapy techniques in the curative treatment of such tumours and the palliative intervention of advanced prostate cancer. He has co-authored international guidelines on prostate cancer management and IPEM guidelines on the implementation of IMRT. In addition he has embedded trial recruitment into his work, is the principle investigator for a number of clinical trials and has presented outcome data of his clinical practice as a matter of routine at various national and international meetings. He is a member of the teaching faculty of the Cambridge Planning Course and has lectured on IMRT and IGRT approaches in head and neck cancers for the past decade.
He is also on the faculty board of the Norwich Skin Cancer course and teaches on the Nottingham MSc Oncology Course. He has had leadership responsibilities within his principle employing organisation for some years and has overseen major service developments. Latterly he has led an executive group in developing and overseeing a strategy to ensure equitable access to research for patients with cancer. In addition to his commissioning responsibilities with the CCG, he is the joint representative for the Midlands and East Radiotherapy Clinical Reference Group.